Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
We constructed a new helper-dependent adenovirus/adeno-associated virus hybrid vector (HD-Ad.AAV hybrid vector) that is composed of the genomic sequence containing BTK exons 2-19, and GFP/puromycin resistant gene. Using this HD-Ad.AAV hybrid vector and CRISPR-Cas9, we found that the targeting in the BTK gene occurred in 10 among 24 hygromycin-resistant BFU-E colonies differentiated from the cord blood CD34+ cells. The estimated targeting efficiency was 1.8 x10-5 per cell. Our study shows the possibility to perform gene repair of BTK gene by homologous recombination in hematopoietic stem cells using this HD-Ad.AAV hybrid vector and CRISPR-Cas9 system.
|